Manalto Price/Sales
Cos'è Price/Sales di Manalto?
Price/Sales di Manalto Limited è 144.59
Qual è la definizione di Price/Sales?
Il rapporto prezzo / vendite è il prezzo delle azioni di una società rispetto ai suoi ricavi.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales di aziende nel Technology settore su ASX rispetto a Manalto
Cosa fa Manalto?
Manalto Limited provides social media management solutions in Australia. The company's social media management platform is a cloud-based social media management software that enables small and large businesses to manage social media presence across various social platforms. It offers a direct-to-market solution that caters for SME's and enterprise businesses. The company was founded in 2011 and is based in Annangrove,, Australia.
Aziende con price/sales simili a Manalto
- ImmuPharma plc ha Price/Sales di 142.96
- John Laing plc ha Price/Sales di 143.03
- Jupiter European Opportunities Trust Plc ha Price/Sales di 143.37
- Nagambie Resources ha Price/Sales di 143.56
- AgeX Therapeutics Inc ha Price/Sales di 144.31
- Stagezero Life Sciences Ltd ha Price/Sales di 144.45
- Manalto ha Price/Sales di 144.59
- Alchemy Resources ha Price/Sales di 147.26
- Encounter Resources ha Price/Sales di 147.36
- Transgene Biotek ha Price/Sales di 147.50
- Applied Energetics ha Price/Sales di 147.78
- Frontier IP Plc ha Price/Sales di 148.07
- Morgan Stanley India Investment Fund Inc ha Price/Sales di 149.50